×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

FARALLON CAPITAL MANAGEMENT LLC

AUM: $42.65 B
13-F Portfolio Value: $24.43 B
Last 13-F Filed: Q3 2025
Concentration in top 10: 48.3%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
ABTABBOTT LABS-136,000Exited13F
AKROAKERO THERAPEUTICS INC-4,000Exited13F
AMEDAMEDISYS INC-575,000Exited13F
ANSSANSYS INC-997,128Exited13F
AZEKAZEK CO INC-3,141,400Exited13F
BYNDBEYOND MEAT INC-19,000Exited13F
BDSXBIODESIX INC-128,000Exited13F
BRKRBRUKER CORP-5,000Exited13F
CHXCHAMPIONX CORPORATION-4,245,000Exited13F
YMMFULL TRUCK ALLIANCE CO LTD-1,550,598Exited13F
HESHESS CORP-5,805,000Exited13F
JANXJANUX THERAPEUTICS INC-48,000Exited13F
JDJD.COM INC (PRN)-40,000,000Exited13F
LTMLATAM AIRLINES GROUP SA-318,092Exited13F
LBRDALIBERTY BROADBAND CORP-58,215Exited13F
LBRDKLIBERTY BROADBAND CORP-4,274,445Exited13F
SPYSPDR S&P 500 ETF TR-5,500,000Exited13F
SAGESAGE THERAPEUTICS INC-42,800Exited13F
SWTXSPRINGWORKS THERAPEUTICS INC-5,000Exited13F
THRDTHIRD HARMONIC BIO INC-15,361Exited13F
UTHRUNITED THERAPEUTICS CORP DEL-1,000Exited13F
VRNAVERONA PHARMA PLC-1,810,000Exited13F
VERVVERVE THERAPEUTICS INC-3,612,000Exited13F
PARAPARAMOUNT GLOBAL-1,346,151Exited13F
VYGRVOYAGER THERAPEUTICS INC-715,000Exited13F
HLXBHELIX ACQUISITION CORP II-600,000Exited13F